CDNA shareholder John Hanna to sell 118,000 shares

CDNA shareholder John Hanna filed a notice indicating plans to sell 118,000 shares of common stock on or about 07/16/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $3,510,500.00.

Rhea-AI Filing Summary

CDNA shareholder John Hanna filed a notice indicating plans to sell 118,000 shares of common stock on or about 07/16/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $3,510,500.00. Shares outstanding were 51,659,481 as reported by the issuer; this is a baseline figure, not the amount being sold.

The shares to be sold are tied to an Exercise of Stock Options for cash. Over the prior three months, Hanna reported several "10b5-1 Sales" of common shares, including 39,900 shares for $1,166,835.60 on 06/29/2026 and 21,998 shares for $528,441.55 on 06/11/2026.

Key Figures

Shares to be sold: 118,000 shares Aggregate market value: $3,510,500.00 Shares outstanding: 51,659,481 shares +3 more

6 metrics

Shares to be sold 118,000 shares Common stock listed under Securities To Be Sold with proposed sale date 07/16/2026

Aggregate market value $3,510,500.00 Market value associated with the 118,000 common shares in the Securities Information section

Shares outstanding 51,659,481 shares Approximate number of common shares outstanding as reported by the issuer

Prior sale on 06/29/2026 39,900 shares for $1,166,835.60 10b5-1 sale of common stock disclosed in Securities Sold During The Past 3 Months

Prior sale on 06/15/2026 17,683 shares for $424,876.39 10b5-1 sale of common stock disclosed in Securities Sold During The Past 3 Months

Prior sale on 06/11/2026 21,998 shares for $528,441.55 10b5-1 sale of common stock disclosed in Securities Sold During The Past 3 Months

Key Terms

10b5-1 Sales, Exercise of Stock Options, Executive Financial Services, Securities To Be Sold

4 terms

10b5-1 Sales regulatory

"10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Exercise of Stock Options financial

"Common | 07/16/2026 | Exercise of Stock Options | Issuer"

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

Securities To Be Sold regulatory

"144: Securities To Be Sold Common | 07/16/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CDNA Form 144 filing report?

It reports that shareholder John Hanna plans to sell 118,000 shares of CDNA common stock on or about 07/16/2026 through Morgan Stanley Smith Barney, via cash exercises of stock options, with an aggregate market value of $3,510,500.00.

How many CDNA shares are outstanding according to this notice?

The notice states there are 51,659,481 common shares outstanding, based on the issuer’s most recent report. This provides context for Hanna’s planned 118,000‑share sale and is a baseline figure, not the amount covered by the transaction.

What prior CDNA share sales are disclosed for John Hanna?

The filing lists several "10b5-1 Sales" of CDNA common shares in the past three months, including 39,900 shares for $1,166,835.60 on 06/29/2026, 17,683 shares for $424,876.39 on 06/15/2026, and 21,998 shares for $528,441.55 on 06/11/2026.

On what market are the CDNA shares proposed to be sold?

The common shares covered by this notice are listed for sale on NASDAQ. The proposed 118,000‑share transaction, valued at $3,510,500.00, is to be executed through Morgan Stanley Smith Barney LLC’s Executive Financial Services platform.

How will the CDNA shares be acquired for sale under this Form 144?

The notice specifies that the common shares to be sold on 07/16/2026 arise from an Exercise of Stock Options and will be paid for in cash. This indicates the seller will exercise options and then sell the resulting 118,000 shares through the broker.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/16/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001781127
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAREDX, INC.
SEC File Number	001-36536
Address of Issuer	8000 Marina Boulevard, 4th Floor Brisbane CALIFORNIA 94005
Phone	4152872300
Name of Person for Whose Account the Securities are To Be Sold	JOHN WALTER HANNA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	118000	3510500.00	51659481	07/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/16/2026	Exercise of Stock Options	Issuer			118000	07/16/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor Brisbane CA 94005	Common	06/29/2026	39900	1166835.60
10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor Brisbane CA 94005	Common	06/26/2026	100	2900.00
10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor Brisbane CA 94005	Common	06/15/2026	17683	424876.39
10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor Brisbane CA 94005	Common	06/11/2026	21998	528441.55
10b5-1 Sales for JOHN HANNA 8000 Marina Boulevard, 4th Floor Brisbane CA 94005	Common	06/04/2026	4835	116044.66

144: Remarks and Signature

Remarks
Date of Notice	07/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ JOHN WALTER HANNA
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)